Weiqi Hong

6.8k total citations · 6 hit papers
43 papers, 3.4k citations indexed

About

Weiqi Hong is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Weiqi Hong has authored 43 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Weiqi Hong's work include SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (9 papers) and Immune cells in cancer (7 papers). Weiqi Hong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (9 papers) and Immune cells in cancer (7 papers). Weiqi Hong collaborates with scholars based in China, United States and Sweden. Weiqi Hong's co-authors include Xiawei Wei, Mengyuan Huang, Min Wu, Xia Zhao, Yang Yang, Hongyi Li, Xuemei He, Guangwen Lu, Xiangyu Pan and Wenyan Ren and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Weiqi Hong

43 papers receiving 3.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

2020 1.2k citations Hongyi Li, Yang Yang et al. Signal Transduction and Targeted Therapy profile →
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

2022 560 citations Weiqi Hong, Xiawei Wei et al. Journal of Hematology & Oncology profile →
SARS‐CoV‐2 Omicron variant: Characteristics and prevention

2021 351 citations Xuemei He, Weiqi Hong et al. SHILAP Revista de lepidopterología profile →
Recent progress in targeted delivery vectors based on biomimetic nanoparticles

2021 258 citations Li Chen, Weiqi Hong et al. Signal Transduction and Targeted Therapy profile →
Molecular mechanisms and therapeutic target of NETosis in diseases

2022 131 citations Jiayu Huang, Weiqi Hong et al. SHILAP Revista de lepidopterología profile →
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants

2023 82 citations Danyi Ao, Xuemei He et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by Weiqi Hong

Since Specialization

Citations

This map shows the geographic impact of Weiqi Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqi Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqi Hong more than expected).

Fields of papers citing papers by Weiqi Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqi Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqi Hong. The network helps show where Weiqi Hong may publish in the future.

Co-authorship network of co-authors of Weiqi Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqi Hong. A scholar is included among the top collaborators of Weiqi Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqi Hong. Weiqi Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway 2025 ·Cancer Communications ·Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei	2
2	A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants 2025 ·Molecular Biomedicine ·Danyi Ao, Dandan Peng, Cai He, (unknown), Weiqi Hong, (unknown), (unknown), Jie Shi, Yingxin Zhang, (unknown), Xiawei Wei, Yuquan Wei	2
3	Immunosenescence: signaling pathways, diseases and therapeutic targets 2025 ·Signal Transduction and Targeted Therapy ·(unknown), (unknown), Aqu Alu, Weiqi Hong, Lei Hong, Xuemei He, Shi H, Ping Cheng, Xiangliang Yang	9
4	Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes 2024 ·Acta Pharmaceutica Sinica B ·Dandan Wan, (unknown), Liang Yu, Li Chen, Haiying Que, Tianxia Lan, Weiqi Hong, Jiayu Huang, He Cai, Yuquan Wei, (unknown), Xiawei Wei	4
5	Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform 2024 ·Cellular and Molecular Immunology ·Jingwen Luo, Fei Mo, Zhe Zhang, Weiqi Hong, Tianxia Lan, Yuan Cheng, Chunju Fang, Zhenfei Bi, (unknown), H. J. Yang, Ziqi Zhang, Xue Li, Haiying Que, Jiayu Wang, Siyuan Chen, WU Yi-ming, Yang Li, Jiong Li, Wei Wang, Chong Chen, Xiawei Wei	4
6	A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2 2023 ·SHILAP Revista de lepidopterología ·Cai He, Aqu Alu, Lei Hong, H. J. Yang, Weiqi Hong, Xiangrong Song, Jiong Li, Li Yang, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei	11
7	Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants 2023 ·Nature Communications ·Lei Hong, Aqu Alu, H. J. Yang, Xi He, Cai He, Wenyan Ren, Zimin Chen, Weiqi Hong, (unknown), Xuemei He, Li Yang, Jiang Li, Zhenling Wang, Wei Wang, Yuquan Wei, Shuaiyao Lu, Guangwen Lu, Xiangrong Song, Xiawei Wei	30
8	Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine 2023 ·Nature Communications ·Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, (unknown), Jieyu Qi, (unknown), Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Xiawei Wei, Zhenhua Shao	21
9	Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection 2023 ·Signal Transduction and Targeted Therapy ·H. J. Yang, Weiqi Hong, Lei Hong, Cai He, Wenwen Lei, Yanan Zhou, Tingmei Zhao, Aqu Alu, Xuelei Ma, (unknown), Li Yang, Zhenling Wang, Wei Wang, Guangwen Lu, Guobo Shen, Shuaiyao Lu, Guizhen Wu, Shi H, Xiawei Wei	20
10	Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses 2023 ·Genes & Diseases ·Li Chen, Wenyan Ren, Hong Lei, Jiayu Wang, Haiying Que, Dandan Wan, Aqu Alu, Dandan Peng, Minyang Fu, Weiqi Hong, (unknown), Xiangrong Song, Guangwen Lu, Xiawei Wei	1
11	Surgical Treatment of Osteosarcoma Induced Distant Pre‐Metastatic Niche in Lung to Facilitate the Colonization of Circulating Tumor Cells 2023 ·Advanced Science ·Fan Tang, Yan Tie, Tianxia Lan, (unknown), Weiqi Hong, (unknown), (unknown), (unknown), Hao Zeng, Min Li, Yuquan Wei, Chongqi Tu, Xiawei Wei	21
12	TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway 2023 ·Journal for ImmunoTherapy of Cancer ·Tianqi Lu, Ziqi Zhang, Zhenfei Bi, Tianxia Lan, Hao Zeng, Yu Liu, Fei Mo, H. J. Yang, Siyuan Chen, Xuemei He, Weiqi Hong, Zhe Zhang, (unknown), Wenyan Ren, Xiaohe Tian, Yuquan Wei, Min Luo, Xiawei Wei	35
13	Cisplatin‐induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP‐1/CCL2 and LTB4/LTB4R pathways 2023 ·Cell Proliferation ·(unknown), (unknown), Weiqi Hong, (unknown), (unknown), H. J. Yang, Ziqi Zhang, Fei Mo, Jing Yang, Qiu Sun, Xiawei Wei	6
14	Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development 2023 ·Medicinal Research Reviews ·Xuemei He, Cai He, Weiqi Hong, H. J. Yang, Xiawei Wei	13
15	Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants 2023 ·Molecular Biomedicine ·Cai He, Li Chen, H. J. Yang, Zimin Chen, Lei Hong, Weiqi Hong, Xiangrong Song, Li Yang, Jiong Li, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei	4
16	The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis breakdown → 2022 ·Journal of Hematology & Oncology ·(unknown), Weiqi Hong, Xiawei Wei	560
17	Secular Difference in Body Mass Index From 2014 to 2020 in Chinese Older Adults: A Time-Series Cross-Sectional Study 2022 ·Frontiers in Nutrition ·Ying Jiang, Xiaomin Zhang, Tianwei Xu, Weiqi Hong, Zhiqi Chen, Xiang Gao, Renying Xu	1
18	Recent progress in targeted delivery vectors based on biomimetic nanoparticles breakdown → 2021 ·Signal Transduction and Targeted Therapy ·Li Chen, Weiqi Hong, Wenyan Ren, Ting Xu, Zhiyong Qian, Zhiyao He	258
19	Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism 2020 ·Frontiers in Cell and Developmental Biology ·Weiqi Hong, Fei Mo, Ziqi Zhang, Mengyuan Huang, Xiawei Wei	136
20	Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects breakdown → 2020 ·Signal Transduction and Targeted Therapy ·Hongyi Li, Yang Yang, Weiqi Hong, Mengyuan Huang, Min Wu, Xia Zhao	1210

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact